Status:
UNKNOWN
The Medication Adherence Program
Lead Sponsor:
University of Washington
Collaborating Sponsors:
American Association of Diabetes Educators
Conditions:
Treatment
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, the investigators will evaluate the impact of a Medication Adherence Program (MAP), a systematic telephone call to patients who are overdue for refills, to assess individual reasons or ...
Detailed Description
Taking medicines can be a challenge for those with diabetes mellitus (DM) with adherence rates to DM medicines as low as 31%. Adherence to DM medicines improves DM by reducing blood glucose (ie A1c re...
Eligibility Criteria
Inclusion
- 18 or older with type 2 diabetes on at least one oral diabetes medication who have missed a refill by 6 or more days
Exclusion
- Those unable to converse in the same language as their usual care Safeway pharmacist (Spanish or English most common languages spoken at the site stores) or who do not have an interpreter, family member, friend, or caregiver who can act on the subject's behalf as an interpreter during the initial or any follow-up phone calls
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00838344
Start Date
April 1 2008
End Date
June 1 2010
Last Update
September 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195